A Study of CPI-613 With Gemcitabine and Nab-paclitaxel for Patients With Advanced or Metastatic Pancreatic Cancer
Clinical trial NCT03435289 · UNKNOWN
Trial details
- NCT number
- NCT03435289
- Sponsor
- Atlantic Health System
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-19
- Primary completion
- 2018-11-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.